Latest Earnings Results: Q2 '26
Estimated EPS
-$0.25
Reported EPS
-$0.21
Surprise
+15.91%
Estimated Rev
$615.44M
Reported Rev
$606.93M
Surprise
-1.38%
$TDOC Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.21 down -10.53% YoY • Reported revenue of $606.93M down -3.95% YoY • Teladoc Health expects full year 2026 revenue of $2,362 to $2,447 million, adjusted EBITDA of $271 to $303 million, and free cash flow in the range of $130 to $170 million.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | -$0.21 | -- | -- | N/A |
Q2 '26 | -$0.25 | -$0.21 | 15.91% | BEAT |
Q1 '26 | -$0.34 | -$0.36 | -5.52% | MISSED |
Q4 '25 | -$0.18 | -$0.14 | 21.92% | BEAT |
Q3 '25 | -$0.26 | -$0.28 | -6.64% | MISSED |